CRISPR/cas9 genome editing is used to insert a a S644G missense mutation (AGT to GGT) in the highly conserved third transmembrane region (TM3). This mutation has been identified in a patient with developmental and epileptic encephalopathy (DEE). (J:307188)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count